Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC).
Phase of Trial: Phase III
Latest Information Update: 23 May 2018
At a glance
- Drugs Tiotropium bromide (Primary) ; Beclometasone; Salmeterol
- Indications Asthma
- Focus Therapeutic Use
- Acronyms TALC
- 08 Apr 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 28 Oct 2010 Results published in the New England Journal of Medicine.
- 17 Sep 2010 Primary endpoint 'Morning peak expiratory flow rate' has been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History